KRYS logo

Krystal Biotech, Inc. (KRYS) Selling, General & Administrative Expenses

Annual SG&A:

$113.69M+$15.29M(+15.53%)
December 31, 2024

Summary

  • As of today, KRYS annual SG&A is $113.69 million, with the most recent change of +$15.29 million (+15.53%) on December 31, 2024.
  • During the last 3 years, KRYS annual SG&A has risen by +$73.30 million (+181.46%).
  • KRYS annual SG&A is now at all-time high.

Performance

KRYS SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKRYSincome statement metrics

Quarterly SG&A:

$0.00-$35.16M(-100.00%)
September 30, 2025

Summary

  • As of today, KRYS quarterly SG&A is $0.00, with the most recent change of -$35.16 million (-100.00%) on September 30, 2025.
  • Over the past year, KRYS quarterly SG&A has dropped by -$28.71 million (-100.00%).
  • KRYS quarterly SG&A is now -100.00% below its all-time high of $35.16 million, reached on June 30, 2025.

Performance

KRYS Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKRYSincome statement metrics

TTM SG&A:

-$459.44M+$198.91M(+30.21%)
September 30, 2025

Summary

  • As of today, KRYS TTM SG&A is -$459.44 million, with the most recent change of +$198.91 million (+30.21%) on September 30, 2025.
  • Over the past year, KRYS TTM SG&A has dropped by -$566.60 million (-528.74%).
  • KRYS TTM SG&A is now -39851.48% below its all-time high of -$1.15 million.

Performance

KRYS TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKRYSincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

KRYS Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+15.5%-100.0%-528.7%
3Y3 Years+181.5%-100.0%-790.1%
5Y5 Years+1658.5%-100.0%-3890.5%

KRYS Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+181.5%-100.0%at lowat high+63.1%
5Y5-Yearat high+1658.5%-100.0%at low-135.0%+63.1%
All-TimeAll-Timeat high>+9999.0%-100.0%at low>-9999.0%+63.1%

KRYS Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2025
-
$0.00(-100.0%)
$99.17M(-22.5%)
Jun 2025
-
$35.16M(+7.4%)
$127.88M(+6.3%)
Mar 2025
-
$32.72M(+4.6%)
$120.35M(+5.9%)
Dec 2024
$113.69M(+15.5%)
$31.29M(+9.0%)
$113.69M(+6.1%)
Sep 2024
-
$28.71M(+3.9%)
$107.16M(+4.9%)
Jun 2024
-
$27.63M(+6.0%)
$102.14M(+1.7%)
Mar 2024
-
$26.06M(+5.2%)
$100.42M(+2.1%)
Dec 2023
$98.40M(+26.6%)
$24.76M(+4.5%)
$98.40M(+0.8%)
Sep 2023
-
$23.70M(-8.5%)
$97.67M(+4.0%)
Jun 2023
-
$25.90M(+7.8%)
$93.90M(+9.4%)
Mar 2023
-
$24.04M(+0.0%)
$85.86M(+10.5%)
Dec 2022
$77.73M(+92.5%)
$24.03M(+20.5%)
$77.74M(+16.8%)
Sep 2022
-
$19.93M(+11.6%)
$66.57M(+18.4%)
Jun 2022
-
$17.86M(+12.3%)
$56.21M(+16.7%)
Mar 2022
-
$15.91M(+23.6%)
$48.15M(+19.2%)
Dec 2021
$40.39M(+168.1%)
$12.87M(+34.4%)
$40.39M(+25.2%)
Sep 2021
-
$9.57M(-2.3%)
$32.27M(+18.3%)
Jun 2021
-
$9.80M(+20.2%)
$27.28M(+31.2%)
Mar 2021
-
$8.15M(+71.7%)
$20.80M(+38.0%)
DateAnnualQuarterlyTTM
Dec 2020
$15.06M(+133.0%)
$4.75M(+3.7%)
$15.06M(+24.3%)
Sep 2020
-
$4.58M(+38.2%)
$12.12M(+34.7%)
Jun 2020
-
$3.31M(+36.9%)
$9.00M(+22.3%)
Mar 2020
-
$2.42M(+34.1%)
$7.36M(+13.8%)
Dec 2019
$6.46M(+55.6%)
$1.80M(+23.9%)
$6.46M(+6.4%)
Sep 2019
-
$1.46M(-13.0%)
$6.08M(+7.0%)
Jun 2019
-
$1.67M(+9.6%)
$5.68M(+15.2%)
Mar 2019
-
$1.53M(+7.8%)
$4.93M(+18.5%)
Dec 2018
$4.16M(+165.7%)
$1.42M(+33.9%)
$4.16M(+32.0%)
Sep 2018
-
$1.06M(+14.5%)
$3.15M(+11.3%)
Jun 2018
-
$924.00K(+22.1%)
$2.83M(+30.1%)
Mar 2018
-
$757.00K(+84.6%)
$2.17M(+39.1%)
Dec 2017
$1.56M(+289.1%)
$410.00K(-44.4%)
$1.56M(+14.0%)
Sep 2017
-
$738.00K(+174.3%)
$1.37M(+92.0%)
Jun 2017
-
$269.00K(+84.2%)
$714.00K(+30.3%)
Mar 2017
-
$146.00K(-33.0%)
$548.00K(+36.3%)
Dec 2016
$402.00K
$218.00K(+169.1%)
$402.00K(+118.5%)
Sep 2016
-
$81.00K(-21.4%)
$184.00K(+78.6%)
Jun 2016
-
$103.00K(>+9900.0%)
$103.00K(>+9900.0%)
Mar 2016
-
$0.00
$0.00

FAQ

  • What is Krystal Biotech, Inc. annual SG&A?
  • What is the all-time high annual SG&A for Krystal Biotech, Inc.?
  • What is Krystal Biotech, Inc. annual SG&A year-on-year change?
  • What is Krystal Biotech, Inc. quarterly SG&A?
  • What is the all-time high quarterly SG&A for Krystal Biotech, Inc.?
  • What is Krystal Biotech, Inc. quarterly SG&A year-on-year change?
  • What is Krystal Biotech, Inc. TTM SG&A?
  • What is the all-time high TTM SG&A for Krystal Biotech, Inc.?
  • What is Krystal Biotech, Inc. TTM SG&A year-on-year change?

What is Krystal Biotech, Inc. annual SG&A?

The current annual SG&A of KRYS is $113.69M

What is the all-time high annual SG&A for Krystal Biotech, Inc.?

Krystal Biotech, Inc. all-time high annual SG&A is $113.69M

What is Krystal Biotech, Inc. annual SG&A year-on-year change?

Over the past year, KRYS annual SG&A has changed by +$15.29M (+15.53%)

What is Krystal Biotech, Inc. quarterly SG&A?

The current quarterly SG&A of KRYS is $0.00

What is the all-time high quarterly SG&A for Krystal Biotech, Inc.?

Krystal Biotech, Inc. all-time high quarterly SG&A is $35.16M

What is Krystal Biotech, Inc. quarterly SG&A year-on-year change?

Over the past year, KRYS quarterly SG&A has changed by -$28.71M (-100.00%)

What is Krystal Biotech, Inc. TTM SG&A?

The current TTM SG&A of KRYS is -$459.44M

What is the all-time high TTM SG&A for Krystal Biotech, Inc.?

Krystal Biotech, Inc. all-time high TTM SG&A is -$1.15M

What is Krystal Biotech, Inc. TTM SG&A year-on-year change?

Over the past year, KRYS TTM SG&A has changed by -$566.60M (-528.74%)
On this page